About Ribometrix
Ribometrix is a company based in Raleigh (United States) founded in 2016. Ribometrix has raised $65.3 million across 11 funding rounds from investors including AbbVie, ARE and Vertex Pharmaceuticals. The company has 26 employees as of December 31, 2022. Ribometrix operates in a competitive market with competitors including Insitro, BridgeBio, ATAI, Forge Biologics and Spark Therapeutics, among others.
- Headquarter Raleigh, United States
- Employees 26 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Ribometrix, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$65.3 M (USD)
in 11 rounds
-
Latest Funding Round
$20 M (USD), Series A
Sep 30, 2019
-
Investors
AbbVie
& 14 more
-
Employee Count
26
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Ribometrix
Unlock access to complete
Unlock access to complete
Funding Insights of Ribometrix
Ribometrix has successfully raised a total of $65.3M across 11 strategic funding rounds. The most recent funding activity was a Series A round of $20 million completed in September 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Ribometrix
Ribometrix has secured backing from 15 investors, including institutional and venture fund investors. Prominent investors backing the company include AbbVie, ARE and Vertex Pharmaceuticals.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital fund focused on early-stage healthcare startups
|
Locked | Locked | Locked | |
|
Health tech startups are invested in by Illumina Ventures.
|
Locked | Locked | Locked | |
|
Tech & Life Sciences focused VC firm investing in early stage companies in the US & Europe
|
Locked | Locked | Locked |
Investor details for Ribometrix
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Ribometrix
Investment portfolio details for Ribometrix
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Ribometrix
Detailed financials for Ribometrix
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ribometrix Comparisons
Peer comparison for Ribometrix
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Ribometrix
Ribometrix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insitro, BridgeBio, ATAI, Forge Biologics and Spark Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
An AI-enabled platform is developed for infectious disease treatment.
|
|
| Locked | Locked | Locked |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| Locked | Locked | Locked |
A biopharmaceutical company accelerating innovative mental health treatments.
|
|
| Locked | Locked | Locked |
Gene therapies for rare diseases are developed to treat patients.
|
|
| Locked | Locked | Locked |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| Locked | Locked | Locked |
Provider of cell therapies to treat cancer and hematologic conditions
|
Detailed competitors of Ribometrix
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ribometrix
Complete news archive for Ribometrix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ribometrix
Ribometrix was founded in 2016.
Ribometrix is headquartered in Raleigh, United States. It is registered at Raleigh, North Carolina, United States.
Ribometrix is a funded company, having raised a total of $65.3M across 11 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Ribometrix is 26.
Founded in 2016, Ribometrix operates in the biotechnology sector from Raleigh, United States. Three-dimensional structural analysis of RNA is employed to support a drug discovery platform. Novel small molecules are identified through this approach to modulate RNA function and associated proteins in human diseases. The platform focuses on therapeutic development for disease-related targets.
Ribometrix's top competitors include Spark Therapeutics, BridgeBio and Forge Biologics.
Ribometrix has 15 investors. Key investors include AbbVie, ARE, Vertex Pharmaceuticals, HHS, and North Carolina Department of Commerce.